Trademark Details For Serial Number 78238050

  •  Home
  •  Print
  • Rank
    Global Trademark Influence Ranking
    3398
0
0
0
0
Basic Information
Serial Number  United States - USPTO 78238050
Registration Number 2813208
Filing Date Apr-15-2003
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0


  • ALLERGAN INC

  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Oct-29-1997

First Use in Commerce: Apr-01-2003


01.15.08
02.01.02
02.03.02
02.11.02



Correspondences

NameCheryl A. Withycombe AbbVie Inc.
Address18655 Teller Avenue Mail code: AND-250C IRVINE, CA 92612 United States

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Sep-05-2003ASSIGNED TO EXAMINER   DOCKD
Sep-05-2003EXAMINERS AMENDMENT E-MAILED   GNEAF
Oct-29-2003NOTICE OF PUBLICATION   NPUBO
Jan-15-2014TEAS SECTION 8 & 9 RECEIVED   E89RI
Sep-18-2003APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Nov-18-2003PUBLISHED FOR OPPOSITION   PUBOA
Feb-10-2004REGISTERED-PRINCIPAL REGISTER   R.PRA
Feb-10-2009TEAS SECTION 8 & 15 RECEIVED   E815I
Feb-13-2009ASSIGNED TO PARALEGAL   PLGLA
Feb-18-2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Jan-15-2014TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Feb-04-2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jan-23-2024TEAS SECTION 8 & 9 RECEIVED   E89RI
May-10-2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
May-10-2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
May-10-2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
May-10-2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E
Feb-10-2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Jan-15-2014REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED   89AFI
Feb-04-2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Feb-04-2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Feb-04-2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E